Vanda Pharmaceuticals Inc.
$5.13
Market Cap
$308.96M
Shares Outstanding
60.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 12, 2006
Round Lot
100
Locale
US
Day Open
$5.08
Day High
$5.15
Day Low
$5.04
Volume
1.66M
VWAP
$5.11
Prev Close
$5.11
Transactions
--
Acc. Volume
--
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Vanda Pharmaceuticals Inc. (VNDA) closed the 2026-09-18 session at $5.13, up 0.39% versus the previous close (+0.02). The stock opened at $5.08 and traded between $5.04 and $5.15 during that session. Session trading volume was 1.7M shares. The volume-weighted average price (VWAP) is $5.11.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Vanda Pharmaceuticals Inc. has a market capitalization of $309.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. VNDA is listed on the XNAS exchange. The company employs approximately 533 people. Vanda Pharmaceuticals Inc. is headquartered in WASHINGTON, DC. The recorded listing date is 2006-04-12.
On this page you can find market VNDA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.